- ENGLISH
- About JBIC
- Board Member
Board Member（as of July11, 2023）
| Chairman | Kouichi Akahane | Former Daiichi Sankyo Co., Ltd. |
|---|---|---|
| Vice-chairman | Kenji Tabata | Astellas Pharma Inc. |
| Tomokazu Yoshida | Sysmex Corporation | |
| President | Hajime Ito | Japan Biological Informatics Consortium |
| Senior Director | Hiroto Itoi | Shimadzu Corporation |
| Kiyoaki Ueno | CeSPIA Inc. | |
| Seiichiro Kumakura | Daiichi Sankyo Co., Ltd. | |
| Takashi Gojobori | King Abdullah University of Science and Technology | |
| Ichio Shimada | RIKEN | |
| Hiroshi Tanaka | Tokyo Medical and Dental University | |
| Kappei Tsukahara | Eisai Co.,Ltd． | |
| Yoshiaki Tsukamoto | Japan Bioindustry Association | |
| Toshiaki Nagasato | Meiji Seika Pharma Co., Ltd. | |
| Tetsuji Nakashima | Fujitsu Limited | |
| Akira Nakayama | Ajinomoto Co.,Inc. | |
| Yo‐ichi Nabeshima | Graduate School of Medicine and Faculty of Medicine Kyoto University | |
| Masao Nawano | Mitsubishi Tanabe Pharma Corporation | |
| Tetsuo Noda | Japanese Foundation for Cancer Research | |
| Hisafumi Yamada | Chugai Pharmaceutical Co.,Ltd. | |
| Masahito Yoshikawa | Toray Industries, Inc. | |
| Kimiaki Narita | Japan Biological Informatics Consortium | |
| Hiroshi Yokota | Japan Biological Informatics Consortium |
Auditor
| Auditor | Takao Sekiya | Princess Takamatsu Cancer Research Fund |
|---|---|---|
| Shinji Kanayama | NIPPON GENE CO., LTD. |
- Research and Development
- Fukushima TranslationalResearch Project
- The development of novel biomarkers stratifying cancer patients based on comprehensive understanding of cancer immunity with immunomonitoring strategies
- Development of innovative drug discovery technologies for middle-sized molecules / Development of production technologies for middle-sized molecules
- Development of innovative drug discovery technologies for middle-sized molecules / Development of simulation technologies for middle-sized molecules
Copyright © 2000-2019 Japan Biological Informatics Consortium All rights reserved.
